ProfileGDS4718 / 233811_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 35% 44% 24% 43% 51% 32% 29% 28% 43% 37% 42% 44% 36% 40% 27% 36% 34% 41% 29% 55% 31% 37% 38% 44% 46% 30% 44% 40% 36% 34% 36% 35% 48% 37% 24% 29% 37% 37% 36% 16% 28% 37% 34% 32% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.7854935
GSM549102patient 115, normal, homogenized [OPG study]5.2288444
GSM549104patient 119, normal, homogenized [OPG study]4.2715824
GSM549108patient 138, normal, homogenized [OPG study]5.1978343
GSM549119patient 077, normal, homogenized [OPG study]5.5772351
GSM549133patient 032, cancer, homogenized [OPG study]4.5801332
GSM549139patient 042, cancer, homogenized [OPG study]4.4684629
GSM549099patient 107, normal, homogenized [OPG study]4.4612928
GSM549109patient 139, normal, homogenized [OPG study]5.1793243
GSM549110patient 046, normal, homogenized [OPG study]4.8687937
GSM549114patient 063, normal, homogenized [OPG study]5.0449142
GSM549122patient 082, normal, homogenized [OPG study]5.1748344
GSM549134patient 033, cancer, homogenized [OPG study]4.7902236
GSM549136patient 036, cancer, homogenized [OPG study]4.9364840
GSM549140patient 044, cancer, homogenized [OPG study]4.3799527
GSM549111patient 047, normal, homogenized [OPG study]4.7859236
GSM549113patient 057, normal, homogenized [OPG study]4.6653734
GSM549132patient 031, cancer, homogenized [OPG study]5.0217841
GSM549137patient 038, cancer, homogenized [OPG study]4.4932429
GSM549142patient 047, cancer, homogenized [OPG study]5.902355
GSM549100patient 110, normal, homogenized [OPG study]4.6171131
GSM549107patient 135, normal, homogenized [OPG study]4.8177137
GSM549115patient 068, normal, homogenized [OPG study]4.8596638
GSM549116patient 072, normal, homogenized [OPG study]5.1817244
GSM549120patient 078, normal, homogenized [OPG study]5.2695846
GSM549131patient 030, cancer, homogenized [OPG study]4.4839730
GSM549118patient 074, normal, homogenized [OPG study]5.1857344
GSM549129patient 027, cancer, homogenized [OPG study]4.9979840
GSM549123patient 088, normal, homogenized [OPG study]4.7908136
GSM549124patient 006, cancer, homogenized [OPG study]4.7650234
GSM549126patient 015, cancer, homogenized [OPG study]4.7714836
GSM549128patient 025, cancer, homogenized [OPG study]4.7607735
GSM549103patient 117, normal, homogenized [OPG study]5.4417748
GSM549117patient 073, normal, homogenized [OPG study]4.7959537
GSM549138patient 041, cancer, homogenized [OPG study]4.2688324
GSM549141patient 045, cancer, homogenized [OPG study]4.4426429
GSM549130patient 028, cancer, homogenized [OPG study]4.8744737
GSM549101patient 111, normal, homogenized [OPG study]4.8994537
GSM549105patient 128, normal, homogenized [OPG study]4.8426236
GSM549106patient 134, normal, homogenized [OPG study]3.948416
GSM549112patient 048, normal, homogenized [OPG study]4.4642628
GSM549125patient 011, cancer, homogenized [OPG study]4.857137
GSM549127patient 024, cancer, homogenized [OPG study]4.7017434
GSM549135patient 035, cancer, homogenized [OPG study]4.5963632